Selected Abstracts of the 2nd Congress of joint European Neonatal Societies (jENS 2017); Venice (Italy); October 31-November 4, 2017; Session "Neonatal Infectious Diseases/Immunology"

Abstract

Selected Abstracts of the 2^nd Congress of joint European Neonatal Societies (jENS 2017); Venice (Italy); October 31-November 4, 2017

58^th ESPR Annual Meeting, 7^th International Congress of UENPS, 3^rd International Congress of EFCNI

ORGANIZING INSTITUTIONS
European Society for Paediatric Research (ESPR), European Society for Neonatology (ESN), Union of European Neonatal & Perinatal Societies (UENPS), European Foundation for the Care of Newborn Infants (EFCNI)

ORGANIZING COMMITTEE
Luc Zimmermann (President of ESPR), Morten Breindahl (President of ESN), Manuel Sánchez Luna (President of UENPS), Silke Mader (Chairwoman of the Executive Board and Co-Founder of EFCNI)

SCIENTIFIC COMMITTEE
Virgilio P. Carnielli (Congress President Chair), Pierre Gressens (Past Scientific President), Umberto Simeoni, Manon Benders, Neil Marlow, Ola D. Saugstad, Petra Hüppi, Agnes van den Hoogen

Session "Neonatal Infectious Diseases/Immunology"

ABS 1. UPTAKE OF PERTUSSIS AND INFLUENZA VACCINES IN PREGNANCY • A. Saso, B. Donaldson, B. Kampmann

ABS 2. THE FREQUENCY OF MANNAN-BINDING LECTIN (MBL) DEFICIENCY IN PREMATURE BABIES AND THE EFFECT ON LONG TERM MORBIDITIES • H. Ozkan, P.Dogan, N. Koksal, B. Oral, O. Bagcı, I. Varal

ABS 3. SEVERE COMBINED IMMUNE DEFICIENCY AND CONTINUED BREASTFEEDING: REPORT OF 5 OWN MOTHER’S MILK DONATION (OMM) AT THE REGIONAL ILE DE FRANCE MILK BANK • V. Rigourd, D. Moshous, J.F. Méritet, M. Nicloux, C. Hovhannisyan, M. Dorsi, T. Hachem, P. Frange, A. Lapillonne, J.F. Magny

ABS 4. MATERNAL CONTRIBUTION TO NEONATAL MICROBIOTA • R.S. Procianoy, L.F. Roesch, A.L. Corso, V. Mai, R.C. Silveira

ABS 5. ANTIMICROBIAL ACTIVITY OF COPPER IN REDUCING ENVIRONMENTAL BURDEN IN A NEONATAL INTENSIVE CARE UNIT (NICU) • Ch. Petropoulou, E. Kouskouni, P. Efstathiou, H. Bouza, Z. Manolidou, K. Karageorgou, A. Efstathiou, M. Logothetis

ABS 6. ANTIBIOTIC EXPOSURE IN NEONATES AND IMPACT ON GUT MICROBIOTA AND ANTIBIOTIC RESISTANCE DEVELOPMENT: A SYSTEMATIC REVIEW • J. Fjalstad, E. Esaiassen, L. Juvet, J. van den Anker, C. Klingenberg

ABS 7. EFFECT OF CATHETER DWELL TIME ON RISK OF CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTION IN NEONATES IN A DEVELOPING HEALTHCARE SYSTEM • S.B. Chaaya, R. Durmush, C.P.H. Ibrahim

ABS 8. 20 YEARS OF EARLY NEONATAL SEPSIS DUE TO E. COLI: SHOULD WE CHANGE EMPIRICAL ANTIBIOTIC THERAPY? • M.C. Céspedes, N. Mendoza, M. Balasch, S. Gonzalez, A. Andreu, M.A. Frick, M.A. Linde, J.J. Gonzalez, P. Soler

ABS 9. COMPARISON OF THE INCIDENCE, CLINICAL FEATURES AND OUTCOMES OF INVASIVE CANDIDIASIS IN CHILDREN AND NEONATES • J.F. Hsu, S.M. Chu, M.H. Tsai

ABS 10. HAND HYGIENE COMPLIANCE IN NICU; AN OBSERVATIONAL STUDY • A. Gürol, K.Ş. Tekgündüz, S. Polat, S. Ejder Tekgündüz, S. Ejder Apay

ABS 11. NEONATAL SEPTIC ARTHRITIS IN NICU • F. Krasniqi, I. Krasniqi, X. Gojnovci, H. Jashari

ABS 12. CURRENT PRACTICE AND NEONATAL STAFF’S KNOWLEDGE ON ANTIBIOTIC USE AND ANTIBIOTIC STEWARDSHIP PROGRAMMES ACROSS TWO NEONATAL NETWORKS • M. Scott, M. Carpenter, P. Satodia, P. Nath

ABS 13. S100-ALARMIN-INDUCED INNATE IMMUNE PROGRAMMING PROTECTS NEWBORN INFANTS FROM SEPSIS • S. Pirr, T. Ulas, B. Fehlhaber, M.S. Bickes, T.G. Loof, T. Vogl, L. Mellinger, A.S. Heinemann, J. Burgmann, J. Schöning, S. Schreek, S. Pfeifer, F. Reuner, L. Völlger, M. Stanulla, M. von Köckritz-Blickwede, S. Glander, K. Barczyk-Kahlert, C.S. von Kaisenberg, J. Friesenhagen, L. Fischer-Riepe, S. Zenker, J.L. Schultze, J. Roth, D. Viemann

ABS 14. HUMAN BREAST MILK SUPPLIES NEWBORN INFANTS WITH HIGH AMOUNTS OF S100-ALARMINS PROTECTING FROM SEPSIS • S. Pirr, M. Richter, J. Pagel, C. Härtel, B. Fehlhaber, J. Roth, T. Vogl, D. Viemann

ABS 15. PREDICTORS OF MORTALITY IN NEONATAL SEPSIS • G.I. Sarosa, R. Rahim

ABS 16. DIAGNOSTIC VALUE LYMPHOCYTE TO NEUTROPHIL RATIO IN PRETERM INFANTS WITH LATE ONSET SEPSIS • S.A. Ozdemir, E.A. Ozer, O. Ilhan, S. Sutcuoglu

ABS 17. C-REACTIVE PROTEIN: AN ADJUNCT OR DILEMMA FOR DIAGNOSIS OF NEONATAL MENINGITIS • F. Yasin, S.F. Virupachi, R.A. Khan

ABS 18. CHARACTERIZATION OF RESISTANCE PLASMIDS DURING A NOSOCOMIAL EPE-OUTBREAK USING OPTICAL DNA MAPPING • S.K. Bikkarolla, V. Nordberg, M.H. Kabir, V. Müller, T. Ambjörnsson, C.G. Giske, L. Navér, L. Sandegren, F. Westerlund

ABS 19. NEONATAL INTESTINAL COLONIZATION WITH ESBL-PRODUCING ENTEROBACTERIACEAE – A 5 YEAR FOLLOW UP STUDY • V. Nordberg, K. Jonsson, C.G. Giske, A. Iversen, O. Aspevall, B. Jonsson, A. Camporeale, M. Norman, L. Navér

ABS 20. DNA VIRUSES: THEIR ROLE IN ACUTE RESPIRATORY INFECTIONS IN NEONATAL UNIT IN TUNISIA • I. Brini, N. Hannachi, A. Guerrero, B. Hetzer, W. Borena, S. Nouri Merchaoui, H. Sboui, D. Von Laer, J. Boukadida, H. Stoiber

ABS 21. OUTCOMES OF CONGENITAL CYTOMEGALOVIRUS DISEASE FOLLOWING MATERNAL PRIMARY AND NON-PRIMARY INFECTION • A. Giannattasio, S. Cenni, D. De Martino, T. Ferrara, L. Capasso, E. Capone, P. Di Costanzo, F. Raimondi

ABS 22. LONG TERM FOLLOW UP OF HEARING DISORDERS IN PATIENTS WITH CONGENITAL CYTOMEGALOVIRUS INFECTION • A. Giannattasio, R. Alfani, P. Di Costanzo, D. Bruzzese, L. Bucci, M.R. Augurio, L. Capasso, F. Raimondi

ABS 23. REVIEW OF ADVERSE VACCINE REACTIONS IN AN IRISH NEONATAL UNIT • C. Fox, E. Gordon

ABS 24. DOES DURATION OF BLOOD CULTURE REPORTING IMPACT ON THE CARE OF NEONATES AT RISK OF EARLY ONSET NEONATAL SEPSIS? • L. Woodgate, C. Chetcuti Ganado

ABS 25. A CANDIDA TROPICALIS OUTBREAK DURING EL NIÑO IN A NEONATAL INTENSIVE CARE UNIT IN SOUTHERN PHILIPPINES • C. Masilungan, R. Aunal, J. Peralta

ABS 26. CONGENITAL CYTOMEGALOVIRUS INFECTION – NEONATAL ASPECT • S. Stefanovic, V. Stefanovic, V. Stefanovic

ABS 27. DIAGNOSTIC VALUE OF SERUM AMYLOID A IN NEONATAL BACTERIAL INFECTIONS AND ASSOCIATIONS WITH CIRCULATING HIGH DENSITY LIPOPROTEIN (HDL) AND CYTOKINE LEVELS • V. Bourika, E. Hantzi, A. Margeli, I. Papassotiriou, T. Siahanidou

ABS 28. CONGENITAL TUBERCULOSIS AS A RESULT OF DISSEMINATED MATERNAL DISEASE. IS CORRECT THE ACTUAL MANAGEMENT? • A.B. Escobar Izquierdo, G. Uclés López, M.J. Cobas Pazos, Y. Lopez Lozano, M.D. Sanchez-Redondo Sanchez-Gabriel, A. Martinez Gimeno

ABS 29. NEONATAL SEPSIS: FREQUENCY, RISK FACTORS AND OUTCOME IN A LEVEL II NICU UNIT • L. Blaga, M. Matyas, C. Vidra, M. Hasmasanu, G. Abrudan, G. Zaharie

ABS 30. LUMBAR PUNCTURE SUCCESS & FAILURE IN A TERTIARY NEONATAL UNIT – A PROSPECTIVE COHORT STUDY • A. Marshall, M. Sadarangani, C. Roehr, M. Anthony

ABS 31. THE EARLY ONSET RISK CALCULATOR TO EVALUATE EARLY-ONSET SEPSIS IN INFANTS BORN ≥ 35 WEEKS GESTATION  • S. Stokes, R. Cuzzilla, AJ. Daley, SE. Jacobs

ABS 32. HOSPITALISATION FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN PREMATURE INFANTS BORN IN MULTIPLE BIRTHS • R. Thwaites, S. Buchan, C. Morris, B. Rodgers-Gray, J. Fullarton, J. Coutts

ABS 33. ANTIBIOTICS FOR EARLY ONSET NEONATAL SEPSIS: AUDITING PRACTICE AND ANALYSING COST • O. Kazeem, M. Saunders, R. Roy, C. Tremlett

ABS 34. DYSFUNCTIONAL INFLAMMATION; THE SIGNIFICANCE OF TLR2 SIGNALING IN HYPOXIC NEONATES PREDISPOSED TO NEURAL ENCEPHALOPATHY • B. Wright, K. Lynne, M. Eleanor, M. Omer, N. A Taher, M. O’Dea, A. Melorz, A. Moreno

ABS 35. NEONATAL THYMIC CHARACTERISTICS IN A RAT MODEL OF INTRAUTERINE GROWTH RESTRICTION • J.B. Armengaud, K. Nardou, F. Pre-Curto, F. Candotti, F. Angelini, M. Hofer, U. Simeoni, C. Yzydorczyk

ABS 36. IMPACT OF MICROBIAL-ASSOCIATED INTRA-AMNIOTIC INFLAMMATION AND “STERILE” INTRA-AMNIOTIC INFLAMMATION ON SHORT-TERM NEONATAL OUTCOME IN WOMEN WITH PRETERM LABOR AND INTACT MEMBRANES • A. Herranz Barbero, R. Amoedo Blanco, M. Izquierdo Renau, C. Murillo, C. Rueda, J. Ponce, T. Cobo

ABS 37. VARIABILITY IN IMMUNOLOGICAL RESPONSE TO OROPHARYNGEAL COLOSTRUM ADMINISTRATION IN PRETERM NEWBORN BASED ON SEX • E. Martin-Alvarez, L. Serrano-Lopez, J. Díaz-Castro, M. Peña-Caballero, M.B. Sánchez-Martínez, F. Martín-Peregrina, J.J. Ochoa, J.A. Hurtado-Suazo

ABS 38. PCT, IL-6 AND IL-8, BUT NOT HA ARE USEFUL FOR DIAGNOSTIC UTILITY IN NEONATES AT RISK THAT FULFILL THE NORWEGIAN CONSENSUS DEFINITION OF NEONATAL SEPSIS • B. Nakstad, H.C.D. Østerholt, A.L. Solevåg

ABS 39. THE ANTISECRETORY FACTOR IN RELATION TO PRETERM BIRTH AND INFLAMMATORY RESPONSE • A. Gustafsson, E. Henckel, E. Johansson, M. Oshalim, S. Lange, A. Olin, P. Brodin, K. Bohlin

ABS 40. NEONATAL INVASIVE CANDIDIASIS: STUDY OF 108 CASES COLLECTED IN NEONATOLOGY DEPARTMENT OF SOUSSE (TUNISIA) • S. Nouri Merchaoui, N. Mahdhaoui, H. Ayache, F. Saghrouni, M. Bellalah, I. Kacem, H. Barbouche, A. Ghith, J. Methlouthi, H. Seboui

ABS 41. HeRO AS A TOOL FOR PREDICTING MORBIDITY AND MORTALITY IN PRETERM INFANTS WITH LATE ONSET SEPSIS ADMITTED TO TERTIARY LEVEL NEONATAL UNIT • E. Hoyle, C. Dewhurst

ABS 42. NEWBORN SCREENING TESTS IN INFANTS WITH CONGENITAL ZIKA VIRUS SYNDROME AND MICROCEPHALY • L. García-Fragoso, L. Gely, S. Rivera-Sánchez, I. García-García

ABS 43. CAN ENDOCAN PREDICT LATE NEONATAL SEPSIS? • M. Buyuktiryaki, N. Okur, C. Tayman, U. Serkant, U. Cakır, H. Halil, M.Y. Oncel, S.S. Oguz

ABS 44. UMBILICAL CORD CARE AND OMPHALITIS IN NEWBORNS OF NORTHERN PORTUGAL: A MULTICENTRIC RETROSPECTIVE STUDY • C. Teles Silva, M. Nogueira, I. Falcão, A.L. Santos, M. Rodrigues, G. Silva, H. Guimarães

ABS 45. CENTRAL LINE ASSOCIATED INFECTION IN NEWBORNS ADMITTED TO A PORTUGUESE NEONATAL INTENSIVE CARE UNIT • T. Lopes, M. Branco, A. Freitas, I. Falcão, C. Carvalho, E. Proença, A. Almeida

ABS 46. NEONATAL INFECTIONS AT PREMATURE AND AT TERM NEWBORN • M. Dima, I. Petre, A. Baros, E.R. Iacob, D. Iacob

ABS 47. PROSTAGLANDIN E2 URINARY METABOLITE IN PRETERM INFANTS. A BIOMARKER FOR INFLAMMATION? • V. Siljehav, L. Gerbaulet, G. Aquilano, A. Honore, S. Psyllidou, M. Vanpée, E. Herlenius

ABS 48. COLONISATION WITH GRAM-NEGATIVE BACTERIA (GNB) IN INFANTS IN A TERTIARY NEONATAL UNIT • C. Kortsalioudaki, M. Sellwood, G. Kendall, B. Shuttleworth, N. Shetty, C.J. Tann, P. Wilson

ABS 49. APPLICATION OF EVIDENCE-BASED MEDICINE METHODS TO DIAGNOSE EARLY NEONATAL SEPSIS • O. Vlasova, L. Koliubakina, L. Bezrukov

ABS 50. NEONATAL BRONCHIOLITIS: CLINICAL PRESENTATION, MANAGEMENT AND PREVENTION • H. Ben Salem, M.T. Lamouchi, M. Sellami, I. Kasraoui, N. Kasdallah, S. Blibech, M. Doagi

ABS 51. SHOULD WE LUMBAR PUNCTURE TERM BABIES BASED ON CRP CRITERIA SET BY NICE? • H. Wood, S. Steadman, J. Gray, V. Rasiah

ABS 52. MENB (BEXSERO®) IMMUNISATION IN NICU: EXPERIENCE IN A UK TERTIARY NEONATAL UNIT POST INTRODUCTION OF VACCINE • A. Mukherjee, S. Senthil, A. Razai, D. Mukherjee